NCT02727582View on ClinicalTrials.gov

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

CompletedOBSERVATIONAL

Enrollment

142

Participants

Timeline

Start Date

July 30, 2015

Primary Completion Date

January 30, 2021

Study Completion Date

January 30, 2021

Conditions

Multidrug-resistant Tuberculosis

Trial Locations (2)

7725

Brooklyn Chest Hospital, Cape Town

DP Marias Hospital, Cape Town

Sponsors

Collaborators (1)

Baylor Research Institute

All Listed Sponsors

collaborator

Baylor Research Institute

OTHER

lead

University of Cape Town

OTHER